Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia
نویسندگان
چکیده
منابع مشابه
Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.
Oral flecainide acetate was administered to 34 patients with documented symptomatic paroxysmal supraventricular tachycardia (PSVT) with a double-blind, placebo-controlled, 8-week crossover trial design. PSVT was defined as a regular tachycardia of at least 120 beats/min without evidence of atrioventricular dissociation. The study required considerable patient cooperation. Patients first entered...
متن کاملNeonatal Supraventricular Tachycardia (SVT)
article. Case Report A male neonate born at 31 weeks’ gestation had a history of fetal supraventricular tachycardia (SVT) detected at 28 weeks’ gestation, with no hydropic changes noticed on ultrasonography. The mother was started on enteral digoxin with instructions for weekly follow-up. On her first return visit at 31 weeks’ gestation, ultrasonography revealed hydropic changes and persistent ...
متن کاملSupraventricular tachycardia. ECG diagnosis and anatomy.
This paper reviews the anatomical substrates responsible for the induction and maintenance of supraventricular tachycardia and discusses the ECG findings associated with these tachycardias. The normal anatomy of the supraventricular conducting system, particularly within the atria, is complex with conduction proceeding along preferential pathway, which are in turn determined in part by the anis...
متن کاملFlecainide Acetate Prevents Recurrence of Symptomatic Paroxysmal Supraventricular Tachycardia
Oral flecainide acetate was administered to 34 patients with documented symptomatic paroxysmal supraventricular tachycardia (PSVT) with a double-blind, placebo-controlled, 8-week crossover trial design. PSVT was defined as a regular tachycardia of at least 120 beats/min without evidence of atrioventricular dissociation. The study required considerable patient cooperation. Patients first entered...
متن کاملSuccessful treatment of fetal supraventricular tachycardia with maternal digoxin therapy.
In a fetus with supraventricular tachycardia (SVT) and cardiac failure, normal sinus rhythm (NSR) was restored with maternal digoxin therapy at 26 weeks' gestation. The diagnosis of cardiac failure was based on ultrasound evidence of ascites and scalp edema. Cardiac failure was attributed to the persistent SVT. The infant remained in NSR and was delivered at 36 weeks' gestation because of persi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Heart
سال: 2003
ISSN: 0007-0769
DOI: 10.1136/heart.89.4.470-a